News and Reports
-
Basilea reports positive topline phase 3 results for antifungal isavuconazole
30 September 2013Download -
Nabriva Therapeutics presented data on potency, safety, tolerability and pharmacokinetics of Pleuromutilin antibiotic BC-3781
13 September 2013Download -
Tensys Medical receives CE Mark for TL-400 & TL-300, latest generations in continuous, non-invasive hemodynamic patient monitoring system
3 September 2013Download -
Ophthotech enrolls first patient in phase 3 clinical trial of Fovista™ Anti-PDGF therapy in combination with Anti-VEGF therapy for wet AMD
29 August 2013Download -
Tensys’ TL-300 receives SFDA approval for Chinese market
21 August 2013Download -
Kolltan enters into license and option agreement with MedImmune
29 July 2013Download -
PTC Therapeutics closes initial public offering
25 June 2013Download -
Basilea awarded contract by BARDA of up to USD 89 million for the development of its novel antibiotic BAL30072
25 June 2013Download -
Curetis raises EUR 12.5M in series B
22 April 2013Download -
Eye diagnostics innovator i-Optics closes EUR 11.8 million financing round
2 April 2013Download -
ENANTA PHharmaceuticals announces closing of initial public offering and exercise of underwriters' over-allotment option
26 March 2013Download -
Women's Health Company Gynesonics Completes USD 21 Million Financing Round
20 February 2013Download -
Tensys Medical Enters Into Exclusive Commercial Agreement With Zhejiang Shanshi Medical Device For T-Line Distribution In China, Hong Kong & Taiwan
12 February 2013Download -
Tensys Medical receives US FDA 510(k) for TL-300, latest generation in continuous, non-invasive hemodynamic patient monitoring system
17 January 2013Download -
MiCardia Corporation’s enCorSQ Mitral Valve Repair System™ Presented During the “Mitral Days Heart Surgery Symposium” in Stuttgart, Germany
4 October 2012Download -
PTC Therapeutics announces achievement of major milestone in Wellcome Trust BMI1 collaboration
11 July 2012Download -
Ophthotech's novel Anti-PDGF combination agent Fovista TM demonstrated superior efficacy over Lucentis monotherapy in large controlled wet AMD trial
13 June 2012Download -
Top-Line data Phase 3 trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis show promising results
8 June 2012Download -
Forest Laboratories and Nabriva Therapeutics sign agreement
1 June 2012Download -
Enanta signs collaboration with Novartis for Hepatitis C programme
22 February 2012Download -
Successful IPO of ChemoCentryx
9 February 2012Download -
ChemoCentryx licenses rheumatoid arthritis drug to GSK
6 January 2012Download -
PTC Therapeutics licenses SMA programme to Roche
30 November 2011Download -
Ellipse receives award for best new technology in spine care
15 November 2011Download -
Probiodrug announces top-line results of the first clinical study of PQ912 for treatment of Alzheimer's disease
14 November 2011Download